Skip to search formSkip to main contentSkip to account menu

NITD 609

Known as: NITD-609, NITD609 
National Institutes of Health

Related topics

Related topics

4 relations

Broader (2)

IndolesSpiro Compounds

Narrower (2)

KAE609cipargamin

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
Evolve and survive
This month's Genome Watch explores how in vitro directed evolution can be used to identify the target of a drug for the treatment… 
2014
2014
Spiroindolone NITD 609 is a novel antimalarial that targets the P-type ATPase PfATP 4
Malaria is caused by the Plasmodium parasite and is a major health problem leading to many deaths worldwide. Lack of a vaccine… 
2012
2012
Mechanistic Study of the Spiroindolones: A New Class of Antimalarials
During the synthesis of the new antimalarial drug candidate NITD609, a high degree of diastereoselectivity was observed in the… 
2011
2011
[New malaria drugs: screening against the entire parasite or target-based - which is the right path?].
2011
2011
Neue Malariawirkstoffe: Screening gegen den kompletten Parasiten oder Target‐basiert – welcher Weg ist der richtige?
Malaria ist immer noch eine der bedeutendsten Infektionskrankheiten der Welt. Der Wert der momentan zur Verfugung stehenden… 
2010
2010
Is the Tide Turning for New Malaria Medicines?
A return to traditional screening methods has rapidly produced a candidate malaria drug. Every so often, the tide turns in a… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)